Patient Management
Improving Outcomes in Cardiogenic Shock Through Best Practices
Prior to discharge from the cath lab and in the ICU, reassess hemodynamics via PA catheter. Best practices include measuring cardiac power output (CPO) and pulmonary artery pulsatility index (PAPi) to evaluate the adequacy of left-sided Impella® support and right heart function, while reducing inotropes.
The AMI cardiogenic shock guidelines present criteria for ongoing patient assessment for myocardial recovery and weaning. If patients meet the criteria for myocardial recovery, wean and explant Impella after a minimum of 48 hours. If recovery is inadequate or there are no signs of recovery in the first 48 to 72 hours, consider escalation of care or transfer.
Patient Management Topics
Cardiogenic Shock Protocol
This download reviews cardiogenic shock guidelines and best practices for identifying, stabilizing, revascularizing and reassessing high-risk cardiogenic shock patients.
Online Calculators
Heparin-Free Purge Solution
Sodium bicarbonate purge solution for Impella® heart pumps received FDA PMA approval in April 2022, as an alternative to heparin, for patients who are intolerant to heparin or in whom heparin is contraindicated (e.g. due to heparin-induced thrombocytopenia or bleeding).
Resources from the Education Library
Additional Services
Impella Connect®
Your cloud-based, remote monitoring of Impella heart pump status. With Impella Connect, authorized hospital staff can review cases at any time from any internet-connected device.
Clinical Support Center
Your on-call resource for 24/7 clinical and technical support. Contact the Clinical Support Center (CSC) at
1-800-422-8666 for patient management expertise to help you achieve the best possible patient outcomes.
NPS-1189